A mutation in PEX19 causes a severe clinical phenotype in a patient with peroxisomal biogenesis disorder.
Peroxisomal biogenesis disorders (PBD) are groups of inherited neurometabolic disorders caused by defects in PEX genes. We report on a female infant, born to a consanguineous parents (first degree cousins), who presented with inactivity, poor sucking, and hypotonia early in the neonatal period. She had subtle dysmorphic features. Liver function tests were impaired with raised liver enzymes, conjugated and unconjugated hyperbilirubinemia. CT of the brain showed diffuse bilateral changes. She developed seizures with an abnormal EEG. Plasma very long chain fatty acid analysis showed high C26:0 levels and increasedC26:0/C22:0 and C24:0/C22:0 ratios, which is consistent with a PBD. Studies in fibroblasts including plasmalogen biosynthesis, peroxisomal fatty acid alfa and beta oxidation confirmed the diagnosis of PBD. Immunofluoresence microscopy revealed the absence of peroxisomes in fibroblasts. The patient was assigned to the PEX19 complementation group. Subsequent mutation analysis of the PEX19 gene revealed homozygosity for a c.320delA frameshift mutation. The patient had a stormy course with multiple admissions to the pediatric intensive care unit with pneumonia, liver impairment, sepsis, and epilepsy. At 1 year of age she developed metabolic acidosis with normal anion gap, proteinuria, aminoaciduria, and glucosuria consistent with a renal tubular defect. Abdominal ultrasound showed multiple gallstones. Other causes of gallstones like haemoglobinopathy were excluded. So far, only two siblings had been reported with mutations in the PEX19 gene. Our patient showed a previously unrecognized association of gallstones and a renal tubular defect with a PBD.
Mohamed
Sarar
S
Department of Pediatrics, Saad Specialist Hospital, Alkhobar, Saudi Arabia. sararmohamed@hotmail.com
El-Meleagy
Ebtisam
E
Nasr
Abdelhaleem
A
Ebberink
Merel S
MS
Wanders
Ronald J A
RJ
Waterham
Hans R
HR
D005260:Female; D016368:Frameshift Mutation; D042882:Gallstones; D006801:Humans; D007223:Infant; D007684:Kidney Tubules / Q000002:abnormalities; D008565:Membrane Proteins / Q000235:genetics*; D018901:Peroxisomal Disorders / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D010641:Phenotype
D008565:Membrane Proteins; C087343:PEX19 protein, human